Antigenic and immunogenic sites of HIV-2 glycoproteins.
Chiodi
F
F
Department of Virology, Karolinska Institute, Stockholm, Sweden.
Björling
E
E
Samuelsson
A
A
Norrby
E
E
D016915:AIDS Vaccines; D000354:Africa, Western / Q000453:epidemiology; D000595:Amino Acid Sequence; D000818:Animals; D004195:Disease Models, Animal; D015686:Gene Products, env; D006168:Guinea Pigs; D015483:HIV Antibodies / Q000276:immunology; D015488:HIV Antigens / Q000235:genetics / Q000276:immunology*; D015699:HIV Envelope Protein gp120 / Q000235:genetics / Q000276:immunology*; D015658:HIV Infections / Q000453:epidemiology; D015497:HIV-1 / Q000235:genetics; D015498:HIV-2 / Q000235:genetics / Q000276:immunology*; D006801:Humans; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000235:genetics / Q000276:immunology*; D011323:Primates; D016415:Sequence Alignment; D017386:Sequence Homology, Amino Acid; D015302:Simian Immunodeficiency Virus / Q000276:immunology; D014611:Vaccination
D016915:AIDS Vaccines; D015686:Gene Products, env; D015483:HIV Antibodies; D015488:HIV Antigens; D015699:HIV Envelope Protein gp120; C059762:HIV envelope protein gp120 (305-321); D010446:Peptide Fragments